PPM1B
Basic information
Region (hg38): 2:44167969-44244384
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPM1B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 22 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 22 | 8 | 2 |
Variants in PPM1B
This is a list of pathogenic ClinVar variants found in the PPM1B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-44201251-G-A | Likely benign (May 17, 2018) | |||
2-44201266-C-T | not specified | Uncertain significance (Oct 12, 2024) | ||
2-44201419-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
2-44201431-C-T | not specified | Uncertain significance (May 23, 2024) | ||
2-44201595-A-T | Likely benign (May 25, 2018) | |||
2-44201612-T-C | not specified | Uncertain significance (Jun 16, 2023) | ||
2-44201632-T-C | not specified | Uncertain significance (Jan 08, 2024) | ||
2-44201643-C-T | Likely benign (Dec 09, 2017) | |||
2-44201657-G-A | not specified | Uncertain significance (Jun 30, 2022) | ||
2-44201669-A-G | not specified | Uncertain significance (Jul 21, 2021) | ||
2-44201677-G-A | not specified | Uncertain significance (Jul 12, 2022) | ||
2-44201680-C-G | not specified | Uncertain significance (May 30, 2024) | ||
2-44201693-C-T | not specified | Uncertain significance (Dec 09, 2023) | ||
2-44201731-G-A | not specified | Uncertain significance (Sep 13, 2023) | ||
2-44201767-C-G | not specified | Uncertain significance (Sep 29, 2023) | ||
2-44201800-G-A | not specified | Uncertain significance (Jun 29, 2023) | ||
2-44202008-A-G | not specified | Uncertain significance (Nov 07, 2022) | ||
2-44202017-A-G | not specified | Uncertain significance (Mar 29, 2022) | ||
2-44202030-C-G | not specified | Uncertain significance (Apr 29, 2024) | ||
2-44209210-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
2-44209312-G-C | not specified | Uncertain significance (Jan 03, 2022) | ||
2-44209318-C-T | not specified | Uncertain significance (Aug 12, 2024) | ||
2-44217978-A-G | not specified | Uncertain significance (Nov 27, 2023) | ||
2-44217986-C-T | Likely benign (Feb 25, 2018) | |||
2-44217998-G-A | not specified | Uncertain significance (Oct 16, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PPM1B | protein_coding | protein_coding | ENST00000282412 | 5 | 76416 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00908 | 0.989 | 125731 | 0 | 17 | 125748 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.600 | 236 | 263 | 0.896 | 0.0000136 | 3149 |
Missense in Polyphen | 45 | 95.308 | 0.47215 | 1118 | ||
Synonymous | 0.701 | 83 | 91.5 | 0.907 | 0.00000465 | 915 |
Loss of Function | 2.68 | 7 | 19.9 | 0.352 | 0.00000116 | 248 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000156 | 0.000156 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000128 | 0.000114 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Enzyme with a broad specificity. Dephosphorylates CDK2 and CDK6 in vitro. Dephosphorylates PRKAA1 and PRKAA2. Inhibits TBK1-mediated antiviral signaling by dephosphorylating it at 'Ser- 172'. Plays an important role in the termination of TNF-alpha- mediated NF-kappa-B activation through dephosphorylating and inactivating IKBKB/IKKB. {ECO:0000269|PubMed:18930133, ECO:0000269|PubMed:22750291}.;
- Pathway
- MAPK signaling pathway - Homo sapiens (human);MAPK Signaling Pathway;Cytokine Signaling in Immune system;Immune System;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling
(Consensus)
Recessive Scores
- pRec
- 0.212
Intolerance Scores
- loftool
- 0.424
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.51
Haploinsufficiency Scores
- pHI
- 1.00
- hipred
- Y
- hipred_score
- 0.792
- ghis
- 0.638
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.965
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ppm1b
- Phenotype
- embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype;
Gene ontology
- Biological process
- protein dephosphorylation;N-terminal protein myristoylation;negative regulation of interferon-beta production;peptidyl-threonine dephosphorylation;negative regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of defense response to virus;negative regulation of NIK/NF-kappaB signaling
- Cellular component
- nucleus;nucleolus;cytosol;membrane
- Molecular function
- magnesium ion binding;protein serine/threonine phosphatase activity;magnesium-dependent protein serine/threonine phosphatase activity;protein binding;manganese ion binding